US5795870A
(en)
*
|
1991-12-13 |
1998-08-18 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
ATE135380T1
(de)
*
|
1991-12-20 |
1996-03-15 |
Hoechst Ag |
Polymere und oligomere von gallensäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
AU664059B2
(en)
*
|
1991-12-20 |
1995-11-02 |
Hoechst Aktiengesellschaft |
Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors
|
IT1258788B
(it)
*
|
1992-01-17 |
1996-02-29 |
Giuliani Spa |
Derivati solforati di acidi biliari
|
DE59307759D1
(de)
*
|
1992-06-12 |
1998-01-15 |
Hoechst Ag |
Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel
|
ES2104208T3
(es)
*
|
1993-03-09 |
1997-10-01 |
Hoechst Ag |
Procedimiento para la preparacion de derivados de acido 3beta-aminocolanico.
|
ES2123133T3
(es)
*
|
1993-03-10 |
1999-01-01 |
Magainin Pharma |
Derivados esteroidianos, composiciones farmaceuticas que contienen estos derivados esteroidianos y utilizacion de estos ultimos como antibioticos o desinfectantes.
|
TW289021B
(no)
*
|
1993-05-08 |
1996-10-21 |
Hoechst Ag |
|
TW289757B
(no)
*
|
1993-05-08 |
1996-11-01 |
Hoechst Ag |
|
TW289020B
(no)
*
|
1993-05-08 |
1996-10-21 |
Hoechst Sktiengesellschaft |
|
EP0624593A3
(de)
*
|
1993-05-08 |
1995-06-07 |
Hoechst Ag |
Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
|
US5624963A
(en)
*
|
1993-06-02 |
1997-04-29 |
Geltex Pharmaceuticals, Inc. |
Process for removing bile salts from a patient and compositions therefor
|
US5585470A
(en)
*
|
1994-06-23 |
1996-12-17 |
Transcell Technologies, Inc. |
Process for the manufacture of 3-amino-substituted glycosylated bile acids
|
US5840740A
(en)
*
|
1995-06-07 |
1998-11-24 |
Magainin Pharmaceuticals Inc. |
Aminosterol compounds and a method of treating infection using the aminosterol compounds
|
US5856535A
(en)
*
|
1994-08-18 |
1999-01-05 |
Magainin Pharmaceuticals, Inc. |
Aminosterol ester compounds
|
DE4432708A1
(de)
*
|
1994-09-14 |
1996-03-21 |
Hoechst Ag |
Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
|
US5583239A
(en)
*
|
1995-05-30 |
1996-12-10 |
Lehigh University |
Antimicrobial sterol conjugates
|
US5874597A
(en)
*
|
1995-06-07 |
1999-02-23 |
Magainin Pharmaceuticals, Inc. |
Certain aminosterol compounds and pharmaceutical compositions including these compounds
|
US5847172A
(en)
*
|
1995-06-07 |
1998-12-08 |
Magainin Pharmaceuticals Inc. |
Certain aminosterol compounds and pharmaceutical compositions including these compounds
|
US5994336A
(en)
*
|
1995-06-07 |
1999-11-30 |
Magainin Pharmaceuticals Inc. |
Method of inhibiting proliferation of cells by administering an aminosterol compound
|
US5795885A
(en)
*
|
1995-06-07 |
1998-08-18 |
Magainin Pharmaceuticals Inc. |
Method of inhibiting profileration of cells by administering an aminosterol compound
|
US5792635A
(en)
*
|
1995-06-07 |
1998-08-11 |
Magainin Pharmaceuticals, Inc. |
Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
|
US5763430A
(en)
*
|
1995-06-07 |
1998-06-09 |
Magainin Pharmaceuticals Inc. |
Method of treating a viral infection by administering a steroid compound
|
US6143738A
(en)
*
|
1995-06-07 |
2000-11-07 |
Magainin Pharmaceuticals, Inc. |
Therapeutic uses for an aminosterol compound
|
US5840936A
(en)
*
|
1995-06-07 |
1998-11-24 |
Magainin Pharmaceuticals Inc. |
Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
|
US5789244A
(en)
*
|
1996-01-08 |
1998-08-04 |
Canji, Inc. |
Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
|
US6392069B2
(en)
*
|
1996-01-08 |
2002-05-21 |
Canji, Inc. |
Compositions for enhancing delivery of nucleic acids to cells
|
US20040014709A1
(en)
*
|
1996-01-08 |
2004-01-22 |
Canji, Inc. |
Methods and compositions for interferon therapy
|
US7002027B1
(en)
*
|
1996-01-08 |
2006-02-21 |
Canji, Inc. |
Compositions and methods for therapeutic use
|
FR2743561B1
(fr)
*
|
1996-01-15 |
1998-02-20 |
Fournier Sca Lab |
Derives de steroides, procede de preparation et utilisation en therapeutique
|
US6596712B2
(en)
|
1996-04-26 |
2003-07-22 |
Genaera Corporation |
Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
|
PT910382E
(pt)
*
|
1996-04-26 |
2003-10-31 |
Genaera Corp |
Esqualamina em combinacao com outros agentes anti-cancro para o tratamento de tumores
|
DE19633268A1
(de)
*
|
1996-08-19 |
1998-02-26 |
Hoechst Ag |
Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung
|
US6262283B1
(en)
|
1996-12-06 |
2001-07-17 |
Magainin Pharmaceuticals Inc. |
Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
|
ES2223091T3
(es)
*
|
1997-04-04 |
2005-02-16 |
Aventis Pharma Deutschland Gmbh |
Derivados de propanolamina hipolipidemicos.
|
DE19845403B4
(de)
*
|
1998-10-02 |
2005-02-10 |
Aventis Pharma Deutschland Gmbh |
Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
DE19950686B4
(de)
*
|
1999-10-21 |
2006-06-29 |
Martin-Luther-Universität Halle-Wittenberg |
Multifunktionelle Spacer
|
EP1235849A2
(en)
*
|
1999-12-09 |
2002-09-04 |
Genaera Corporation |
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
|
DE60123939T2
(de)
*
|
2000-04-12 |
2007-05-31 |
Genaera Corp. |
Ein verfahren zur herstellung von 7.alpha.-hydroxy 3-aminosubstituierten sterol-verbindungen, ohne schutz der 7.alpha.-hydroxy-gruppe
|
US8975246B2
(en)
|
2001-04-17 |
2015-03-10 |
Galmed Research And Development Ltd. |
Bile acid or bile salt fatty acid conjugates
|
SI1456377T1
(sl)
*
|
2001-12-20 |
2019-09-30 |
Merck Sharp & Dohme Corp. |
Sestavki SYN3 in postopki
|
US7141559B2
(en)
|
2002-06-19 |
2006-11-28 |
Karo Bio Ab |
Glucocorticoid receptor ligands for the treatment of metabolic disorders
|
WO2004000869A1
(en)
*
|
2002-06-19 |
2003-12-31 |
Karo Bio Ab |
Glucocorticoid receptor ligands for the treatment of metabolic disorders
|
GB0307918D0
(en)
|
2003-04-05 |
2003-05-14 |
Astrazeneca Ab |
Therapeutic use
|
CN1845932A
(zh)
|
2003-06-04 |
2006-10-11 |
坎基股份有限公司 |
转染剂
|
US7235678B2
(en)
*
|
2004-03-30 |
2007-06-26 |
Council Of Scientific And Industrial Research |
Bile acid derived steroidal dimers with novel amphiphilic topology having antifungal activity
|
US20050225942A1
(en)
*
|
2004-04-07 |
2005-10-13 |
First International Computer Inc. |
Plug-in cooling device
|
ES2318922B1
(es)
*
|
2005-05-30 |
2010-02-12 |
Universidade De Santiago De Compostela |
Nuevos dimeros derivados de acidos biliares funcionalizados en la posicion 3 del anillo a. metodo para la sintesis y aplicaciones.
|
ES2318927B1
(es)
*
|
2005-08-25 |
2010-02-12 |
Universidade De Santiago De Compostela |
Nuevos dimeros de acidos biliares funcionalizados en la posicion 24 de la cadena alquilica de la sal biliar. procedimientos para su obtencion y aplicaciones.
|
US7960439B1
(en)
|
2006-06-12 |
2011-06-14 |
Iowa State University Research Foundation, Inc. |
Environmentally sensitive foldable oligomers
|
US7962543B2
(en)
*
|
2007-06-01 |
2011-06-14 |
Advanced Micro Devices, Inc. |
Division with rectangular multiplier supporting multiple precisions and operand types
|
KR101289199B1
(ko)
|
2008-08-28 |
2013-07-29 |
한양대학교 산학협력단 |
수용성기를 포함한 바일산 유도체 및 그의 응용
|
US20120301457A1
(en)
*
|
2010-01-22 |
2012-11-29 |
Surachai Supattapone |
LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
|
ES2552657T3
(es)
|
2010-05-26 |
2015-12-01 |
Satiogen Pharmaceuticals, Inc. |
Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias
|
PL2637646T3
(pl)
|
2010-11-08 |
2017-01-31 |
Albireo Ab |
Kombinacja farmaceutyczna zawierająca inhibitor ibat i środek wiążący kwasy żółciowe
|
DK3400944T3
(da)
|
2010-11-08 |
2020-10-12 |
Albireo Ab |
Ibat-inhibitorer til behandling af leversygdomme
|
PL2771003T3
(pl)
|
2011-10-28 |
2017-10-31 |
Lumena Pharmaceuticals Llc |
Inhibitory ponownego wykorzystania kwasów żółciowych do leczenia pediatrycznych cholestatycznych chorób wątroby
|
CN104023718B
(zh)
|
2011-10-28 |
2017-04-05 |
鲁美纳医药公司 |
用于治疗高胆血症和胆汁淤积性肝病的胆汁酸再循环抑制剂
|
MX2015013196A
(es)
|
2013-03-15 |
2016-04-15 |
Lumena Pharmaceuticals Inc |
Inhibidores de reciclaje de acidos biliares para el tratamiento de la enfermedad de reflujo gastroesofagico y esofago de barrett.
|
CA2907230A1
(en)
|
2013-03-15 |
2014-09-18 |
Lumena Pharmaceuticals, Inc. |
Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
|
JO3301B1
(ar)
|
2013-04-26 |
2018-09-16 |
Albireo Ab |
تعديلات بلورية على إيلوبيكسيبات
|
WO2015199147A1
(ja)
|
2014-06-25 |
2015-12-30 |
味の素株式会社 |
固形製剤及びその着色防止又は着色低減方法
|
EP3012252A1
(en)
|
2014-10-24 |
2016-04-27 |
Ferring BV |
Crystal modifications of elobixibat
|
US10441605B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
US10786529B2
(en)
|
2016-02-09 |
2020-09-29 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
US10441604B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
CA3011565C
(en)
|
2016-02-09 |
2024-01-02 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
EP3413878B1
(en)
|
2016-02-09 |
2021-04-14 |
Albireo AB |
Oral cholestyramine formulation and use thereof
|
JP7328207B2
(ja)
|
2017-08-09 |
2023-08-16 |
アルビレオ・アクチボラグ |
コレスチラミンペレット、経口コレスチラミン製剤、及びそれらの使用
|
EP3664781A1
(en)
|
2017-08-09 |
2020-06-17 |
Albireo AB |
Cholestyramine granules, oral cholestyramine formulations and use thereof
|
KR20200121816A
(ko)
|
2018-02-02 |
2020-10-26 |
리플 테라퓨틱스 코포레이션 |
스테로이드 이량체를 포함하는 유리 제제 및 이의 용도
|
US10793534B2
(en)
|
2018-06-05 |
2020-10-06 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
TW202015699A
(zh)
|
2018-06-05 |
2020-05-01 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途
|
US11801226B2
(en)
|
2018-06-20 |
2023-10-31 |
Albireo Ab |
Pharmaceutical formulation of odevixibat
|
SG11202012151XA
(en)
|
2018-06-20 |
2021-01-28 |
Albireo Ab |
Crystal modifications of odevixibat
|
US11007142B2
(en)
|
2018-08-09 |
2021-05-18 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
US10722457B2
(en)
|
2018-08-09 |
2020-07-28 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
US11549878B2
(en)
|
2018-08-09 |
2023-01-10 |
Albireo Ab |
In vitro method for determining the adsorbing capacity of an insoluble adsorbant
|
SG11202108566VA
(en)
|
2019-02-06 |
2021-09-29 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
US10975045B2
(en)
|
2019-02-06 |
2021-04-13 |
Aibireo AB |
Benzothiazepine compounds and their use as bile acid modulators
|
EP3921027B1
(en)
|
2019-02-06 |
2023-07-19 |
Albireo AB |
Benzothiazepine compounds and their use as bile acid modulators
|
US10941127B2
(en)
|
2019-02-06 |
2021-03-09 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
CN114096268A
(zh)
|
2019-02-12 |
2022-02-25 |
米鲁姆制药公司 |
用于增加患有胆汁淤积性肝病的儿科受试者的生长的方法
|
TW202134220A
(zh)
|
2019-12-04 |
2021-09-16 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
|
EP4069361B1
(en)
|
2019-12-04 |
2024-01-03 |
Albireo AB |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
TW202134218A
(zh)
|
2019-12-04 |
2021-09-16 |
瑞典商艾爾比瑞歐公司 |
苯并噻氮呯化合物及其作為膽酸調節劑之用途
|
CA3158184A1
(en)
|
2019-12-04 |
2021-08-10 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
US11014898B1
(en)
|
2020-12-04 |
2021-05-25 |
Albireo Ab |
Benzothiazepine compounds and their use as bile acid modulators
|
PT4069360T
(pt)
|
2019-12-04 |
2024-03-06 |
Albireo Ab |
Compostos de benzotia(di)azepina e a sua utilização como moduladores de ácido biliar
|
TW202134221A
(zh)
|
2019-12-04 |
2021-09-16 |
瑞典商艾爾比瑞歐公司 |
苯并噻二氮呯化合物及其作為膽酸調節劑之用途
|
WO2021110884A1
(en)
|
2019-12-04 |
2021-06-10 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
EP4069359B1
(en)
|
2019-12-04 |
2024-01-03 |
Albireo AB |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
KR20220109450A
(ko)
|
2019-12-04 |
2022-08-04 |
알비레오 에이비 |
벤조티아(디)아제핀 화합물 및 담즙산 조절제로서의 이의 용도
|
CA3176134A1
(en)
|
2020-05-01 |
2021-11-04 |
Ripple Therapeutics Corporation |
Heterodimer compositions and methods for the treatment of ocular disorders
|
CA3186857A1
(en)
|
2020-08-03 |
2022-02-10 |
Per-Goran Gillberg |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
WO2022029101A1
(en)
|
2020-08-03 |
2022-02-10 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
KR20230106651A
(ko)
|
2020-11-12 |
2023-07-13 |
알비레오 에이비 |
진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트
|
JP2024500309A
(ja)
|
2020-12-04 |
2024-01-09 |
アルビレオ エービー |
ベンゾチア(ジ)アゼピン化合物および胆汁酸モジュレータとしてのその使用
|
TW202313579A
(zh)
|
2021-06-03 |
2023-04-01 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
|
WO2023216423A1
(zh)
*
|
2022-05-13 |
2023-11-16 |
苏州慧疗生物医药科技有限公司 |
脂质化合物及其组合物,制备和用途
|
US20230398125A1
(en)
|
2022-06-09 |
2023-12-14 |
Albireo Ab |
Treating hepatitis
|
WO2024008766A1
(en)
|
2022-07-05 |
2024-01-11 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
WO2024121434A1
(en)
|
2022-12-09 |
2024-06-13 |
Albireo Ab |
Asbt inhibitors in the treatment of renal diseases
|